Pharmacogenetics: optimising prescribing in primary care

Essra Youssef, Tracey Thornley, David Wright, Henk-Jan Guchelaar

Research output: Contribution to journalArticlepeer-review

3 Downloads (Pure)

Abstract

Pharmacogenetic (PGx) testing to personalise prescribing of certain medicines can improve patient outcomes and reduce adverse drug reactions. This article summarises the key findings of the PGx Impact study, designed to estimate the impact of pre-emptive genetic testing on prescribing, and discusses potential ways in which pharmacogenetic testing may optimise primary care prescribing in the near future.
Original languageEnglish
Pages (from-to)10-13
Number of pages4
JournalPrescriber
Volume33
Issue number5
DOIs
Publication statusPublished - May 2022

Cite this